Limited access to essential medicines for treating chronic diseases is a major challenge in low and middle-income countries. Although India is the largest manufacturer of generic medicines, there is a paucity of information on availability, price and affordability of essential anti-cancer medicines used for treating childhood cancers.
For the first time, the World Health Organisation’s World Health Statistics have this year been disaggregated by sex. This is an important step forward in the drive to identify and understand gender inequalities, and one that is to be welcomed wholeheartedly.
A study of 1.4 million adults in England has found that the most socioeconomically deprived are 68% more likely to develop advanced chronic kidney disease (CKD) than the least deprived, so experience poorer health outcomes and quality of life.
The first-ever National Symposium on Evidence Synthesis for Medicine, Public Health and Social Development (NSES 2019) organised by The George Institute for Global Health, India and the Campbell Collaboration in the Capital concluded on Friday with a clarion call to young researchers, knowledge brokers and policy-makers to work together to usher in the evidence revolution and ensure that the fields of public health, medicine and social development are informed by good science.
The George Institute for Global Health India, and the University of Oxford UK, jointly hosted two national stakeholder meetings, in New Delhi on 29th March 2019 and in Vijayawada on 1st April, to identify priorities and challenges to integrate screening and management of non-communicable diseases into maternal and child health services in India.